Dr. Stephen Baylin discusses his 2018 AACR meeting presentation on SU2C research into using epigenetic therapy to boost immune checkpoint therapy.
Stephen Baylin, MD
Advertisement
Articles by Stephen Baylin, MD
Advertisement
Latest Updated Articles
Uncovering Epigenetic Targets in CancerPublished: April 11th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
3
SCT with Melphalan/Ascorbic Acid Safe for BRCA-Mutated PDAC
4
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
5
